Literature DB >> 23674381

Osteogenesis imperfecta without features of type V caused by a mutation in the IFITM5 gene.

Monica Grover1, Philippe M Campeau, Caressa Dee Lietman, James T Lu, Richard A Gibbs, Alan E Schlesinger, Brendan H Lee.   

Abstract

Osteogenesis imperfecta (OI) is typically caused by mutations in type 1 collagen genes, but in recent years new recessive and dominant forms caused by mutations in a plethora of different genes have been characterized. OI type V is a dominant form caused by the recurrent (c.-14C > T) mutation in the 5'UTR of the IFITM5 gene. The mutation adds five residues to the N-terminus of the IFITM5, but the pathophysiology of the disease remains to be elucidated. Typical clinical features present in the majority of OI type V patients include interosseous membrane calcification between the radius and ulna and between the tibia and fibula, radial head dislocation, and significant hyperplastic callus formation at the site of fractures. We report a 5-year-old child with clinical features of OI type III or severe OI type IV (characteristic facies, gray sclerae, typical fractures) and absence of classical features of OI type V with a de novo recurrent IFITM5 mutation (c.-14C > T), now typical of OI type V. This highlights the variability of OI caused by IFITM5 mutations and suggests screening for mutations in this gene in most cases of OI where type 1 collagen mutations are absent.
© 2013 American Society for Bone and Mineral Research.

Entities:  

Keywords:  HYPERPLASTIC CALLUS; IFITM5; INTEROSSEOUS MEMBRANE CALCIFICATION; OSTEOGENESIS IMPERFECTA; TYPE V; WHOLE EXOME SEQUENCING

Mesh:

Substances:

Year:  2013        PMID: 23674381      PMCID: PMC3800501          DOI: 10.1002/jbmr.1983

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  17 in total

1.  The Atlas genome assembly system.

Authors:  Paul Havlak; Rui Chen; K James Durbin; Amy Egan; Yanru Ren; Xing-Zhi Song; George M Weinstock; Richard A Gibbs
Journal:  Genome Res       Date:  2004-04       Impact factor: 9.043

2.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.

Authors:  Aaron McKenna; Matthew Hanna; Eric Banks; Andrey Sivachenko; Kristian Cibulskis; Andrew Kernytsky; Kiran Garimella; David Altshuler; Stacey Gabriel; Mark Daly; Mark A DePristo
Journal:  Genome Res       Date:  2010-07-19       Impact factor: 9.043

3.  Bril: a novel bone-specific modulator of mineralization.

Authors:  Pierre Moffatt; Marie-Helene Gaumond; Patrick Salois; Karine Sellin; Marie-Claude Bessette; Eric Godin; Paulo Tambasco de Oliveira; Gerald J Atkins; Antonio Nanci; Gethin Thomas
Journal:  J Bone Miner Res       Date:  2008-09       Impact factor: 6.741

Review 4.  Classification of Osteogenesis Imperfecta revisited.

Authors:  F S Van Dijk; G Pals; R R Van Rijn; P G J Nikkels; J M Cobben
Journal:  Eur J Med Genet       Date:  2009-10-28       Impact factor: 2.708

5.  Type V osteogenesis imperfecta: a new form of brittle bone disease.

Authors:  F H Glorieux; F Rauch; H Plotkin; L Ward; R Travers; P Roughley; L Lalic; D F Glorieux; F Fassier; N J Bishop
Journal:  J Bone Miner Res       Date:  2000-09       Impact factor: 6.741

6.  Genetic heterogeneity in osteogenesis imperfecta.

Authors:  D O Sillence; A Senn; D M Danks
Journal:  J Med Genet       Date:  1979-04       Impact factor: 6.318

7.  The Sequence Alignment/Map format and SAMtools.

Authors:  Heng Li; Bob Handsaker; Alec Wysoker; Tim Fennell; Jue Ruan; Nils Homer; Gabor Marth; Goncalo Abecasis; Richard Durbin
Journal:  Bioinformatics       Date:  2009-06-08       Impact factor: 6.937

8.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data.

Authors:  Kai Wang; Mingyao Li; Hakon Hakonarson
Journal:  Nucleic Acids Res       Date:  2010-07-03       Impact factor: 16.971

Review 9.  Osteogenesis imperfecta.

Authors:  Frank Rauch; Francis H Glorieux
Journal:  Lancet       Date:  2004-04-24       Impact factor: 79.321

10.  Phenotypic variability of osteogenesis imperfecta type V caused by an IFITM5 mutation.

Authors:  Jay R Shapiro; Caressa Lietman; Monica Grover; James T Lu; Sandesh Cs Nagamani; Brian C Dawson; Dustin M Baldridge; Matthew N Bainbridge; Dan H Cohn; Maria Blazo; Timothy T Roberts; Feng-Shu Brennen; Yimei Wu; Richard A Gibbs; Pamela Melvin; Philippe M Campeau; Brendan H Lee
Journal:  J Bone Miner Res       Date:  2013-07       Impact factor: 6.741

View more
  14 in total

Review 1.  IFITM5 mutations and osteogenesis imperfecta.

Authors:  Nobutaka Hanagata
Journal:  J Bone Miner Metab       Date:  2015-06-02       Impact factor: 2.626

Review 2.  Osteogenesis imperfecta in children and adolescents-new developments in diagnosis and treatment.

Authors:  P Trejo; F Rauch
Journal:  Osteoporos Int       Date:  2016-08-05       Impact factor: 4.507

3.  PHENOTYPIC VARIABILITY IN INDIVIDUALS WITH TYPE V OSTEOGENESIS IMPERFECTA WITH IDENTICAL IFITM5 MUTATIONS.

Authors:  Jamie Fitzgerald; Paul Holden; Hollis Wright; Beth Wilmot; Abigail Hata; Robert D Steiner; Don Basel
Journal:  J Rare Disord       Date:  2013-12

4.  Hypermineralization and High Osteocyte Lacunar Density in Osteogenesis Imperfecta Type V Bone Indicate Exuberant Primary Bone Formation.

Authors:  Stéphane Blouin; Nadja Fratzl-Zelman; Francis H Glorieux; Paul Roschger; Klaus Klaushofer; Joan C Marini; Frank Rauch
Journal:  J Bone Miner Res       Date:  2017-06-26       Impact factor: 6.741

Review 5.  Genetic causes and mechanisms of Osteogenesis Imperfecta.

Authors:  Joohyun Lim; Ingo Grafe; Stefanie Alexander; Brendan Lee
Journal:  Bone       Date:  2017-02-15       Impact factor: 4.398

6.  Clinical and Molecular Characterization of Osteogenesis Imperfecta Type V.

Authors:  Evelise Brizola; Eduardo P Mattos; Jessica Ferrari; Patricia O A Freire; Raquel Germer; Juan C Llerena; Têmis M Félix
Journal:  Mol Syndromol       Date:  2015-09-03

Review 7.  Recent developments in osteogenesis imperfecta.

Authors:  Joseph L Shaker; Carolyne Albert; Jessica Fritz; Gerald Harris
Journal:  F1000Res       Date:  2015-09-07

8.  The IFITM5 mutation c.-14C > T results in an elongated transcript expressed in human bone; and causes varying phenotypic severity of osteogenesis imperfecta type V.

Authors:  Syndia Lazarus; Aideen M McInerney-Leo; Fiona A McKenzie; Gareth Baynam; Stephanie Broley; Barbra V Cavan; Craig F Munns; Johannes Egbertus Hans Pruijs; David Sillence; Paulien A Terhal; Karena Pryce; Matthew A Brown; Andreas Zankl; Gethin Thomas; Emma L Duncan
Journal:  BMC Musculoskelet Disord       Date:  2014-03-27       Impact factor: 2.362

Review 9.  IFITMs restrict the replication of multiple pathogenic viruses.

Authors:  Jill M Perreira; Christopher R Chin; Eric M Feeley; Abraham L Brass
Journal:  J Mol Biol       Date:  2013-09-25       Impact factor: 5.469

10.  A novel variant of the IFITM5 gene within the 5'-UTR causes neonatal transverse clavicular fracture: Expanding the genetic spectrum.

Authors:  Dong Wu; Yuxin Wang; Huijuan Huang
Journal:  Mol Genet Genomic Med       Date:  2020-05-08       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.